195 related articles for article (PubMed ID: 32809822)
21. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification.
Reiding KR; Blank D; Kuijper DM; Deelder AM; Wuhrer M
Anal Chem; 2014 Jun; 86(12):5784-93. PubMed ID: 24831253
[TBL] [Abstract][Full Text] [Related]
22. Dried blood spot N-glycome analysis by MALDI mass spectrometry.
Vreeker GCM; Bladergroen MR; Nicolardi S; Mesker WE; Tollenaar RAEM; van der Burgt YEM; Wuhrer M
Talanta; 2019 Dec; 205():120104. PubMed ID: 31450448
[TBL] [Abstract][Full Text] [Related]
23. A rapid sample preparation method for mass spectrometric characterization of N-linked glycans.
Yu YQ; Gilar M; Kaska J; Gebler JC
Rapid Commun Mass Spectrom; 2005; 19(16):2331-6. PubMed ID: 16041822
[TBL] [Abstract][Full Text] [Related]
24. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
25. Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF.
Ruhaak LR; Hennig R; Huhn C; Borowiak M; Dolhain RJ; Deelder AM; Rapp E; Wuhrer M
J Proteome Res; 2010 Dec; 9(12):6655-64. PubMed ID: 20886907
[TBL] [Abstract][Full Text] [Related]
26. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.
Powers TW; Neely BA; Shao Y; Tang H; Troyer DA; Mehta AS; Haab BB; Drake RR
PLoS One; 2014; 9(9):e106255. PubMed ID: 25184632
[TBL] [Abstract][Full Text] [Related]
27. High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time-of-flight mass spectrometry.
Gil GC; Iliff B; Cerny R; Velander WH; Van Cott KE
Anal Chem; 2010 Aug; 82(15):6613-20. PubMed ID: 20586471
[TBL] [Abstract][Full Text] [Related]
28. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
29. Permethylated N-glycan analysis with mass spectrometry.
Lin Z; Lubman DM
Methods Mol Biol; 2013; 1007():289-300. PubMed ID: 23666731
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the glycosylation pattern of plant copper amine oxidases by MALDI-TOF/TOF MS coupled to a manual chromatographic separation of glycans and glycopeptides.
Franc V; Řehulka P; Medda R; Padiglia A; Floris G; Šebela M
Electrophoresis; 2013 Aug; 34(16):2357-67. PubMed ID: 23580492
[TBL] [Abstract][Full Text] [Related]
31. In Situ Imaging of N-Glycans by MALDI Imaging Mass Spectrometry of Fresh or Formalin-Fixed Paraffin-Embedded Tissue.
Drake RR; Powers TW; Norris-Caneda K; Mehta AS; Angel PM
Curr Protoc Protein Sci; 2018 Nov; 94(1):e68. PubMed ID: 30074304
[TBL] [Abstract][Full Text] [Related]
32. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.
Guillard M; Morava E; van Delft FL; Hague R; Körner C; Adamowicz M; Wevers RA; Lefeber DJ
Clin Chem; 2011 Apr; 57(4):593-602. PubMed ID: 21273509
[TBL] [Abstract][Full Text] [Related]
33. Rapid quantitative profiling of N-glycan by the glycan-labeling method using 3-aminoquinoline/α-cyano-4-hydroxycinnamic acid.
Kaneshiro K; Watanabe M; Terasawa K; Uchimura H; Fukuyama Y; Iwamoto S; Sato TA; Shimizu K; Tsujimoto G; Tanaka K
Anal Chem; 2012 Aug; 84(16):7146-51. PubMed ID: 22830976
[TBL] [Abstract][Full Text] [Related]
34. Simplifying Glycan Profiling through a High-Throughput Micropermethylation Strategy.
Shajahan A; Supekar NT; Chapla D; Heiss C; Moremen KW; Azadi P
SLAS Technol; 2020 Aug; 25(4):367-379. PubMed ID: 32364434
[TBL] [Abstract][Full Text] [Related]
35. Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS.
Shubhakar A; Kozak RP; Reiding KR; Royle L; Spencer DI; Fernandes DL; Wuhrer M
Anal Chem; 2016 Sep; 88(17):8562-9. PubMed ID: 27479043
[TBL] [Abstract][Full Text] [Related]
36. High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.
Kam RK; Poon TC; Chan HL; Wong N; Hui AY; Sung JJ
Clin Chem; 2007 Jul; 53(7):1254-63. PubMed ID: 17510303
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
38. Regional N-glycan and lipid analysis from tissues using MALDI-mass spectrometry imaging.
Stanback AE; Conroy LR; Young LEA; Hawkinson TR; Markussen KH; Clarke HA; Allison DB; Sun RC
STAR Protoc; 2021 Mar; 2(1):100304. PubMed ID: 33554139
[TBL] [Abstract][Full Text] [Related]
39. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum.
Hu Y; Mechref Y
Electrophoresis; 2012 Jul; 33(12):1768-77. PubMed ID: 22740465
[TBL] [Abstract][Full Text] [Related]
40. Size-selective enrichment of N-linked glycans using highly ordered mesoporous carbon material and detection by MALDI-TOF MS.
Qin H; Zhao L; Li R; Wu R; Zou H
Anal Chem; 2011 Oct; 83(20):7721-8. PubMed ID: 21899340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
